Evidence map›Paper›PMID 40370229›Full record

ReviewRecent advances in drug delivery and formulation2026

Advancement in Nanotablet Research: An Overview.

Aparna Gupta, Gaurav Thakur, Peeyush Kaushik, Sandhya Jaiswal, Jyoti Singh, Saurabh Sharma, Sunny Dhiman, Supriya Agnihotri

Abstract readReview
PubMed Publisher
In one paragraph

Review in Recent advances in drug delivery and formulation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Aparna GuptaDepartment of Pharmaceutical sciences, Chandigarh College of Pharmacy, Landran, Mohali, Punjab, 140307, India.
Gaurav ThakurDepartment of Pharmaceutical sciences, Chandigarh College of Pharmacy, Landran, Mohali, Punjab, 140307, India.
Peeyush KaushikDepartment of Pharmaceutical sciences, Chandigarh College of Pharmacy, Landran, Mohali, Punjab, 140307, India.
Sandhya JaiswalDepartment of Pharmaceutical sciences, Chandigarh College of Pharmacy, Landran, Mohali, Punjab, 140307, India.
Jyoti SinghDepartment of Pharmaceutical sciences, Chandigarh College of Pharmacy, Landran, Mohali, Punjab, 140307, India.
Saurabh SharmaDepartment of Pharmaceutical sciences, Chandigarh College of Pharmacy, Landran, Mohali, Punjab, 140307, India.
Sunny DhimanDepartment of Pharmaceutical sciences, Chandigarh College of Pharmacy, Landran, Mohali, Punjab, 140307, India.
Supriya AgnihotriDepartment of Pharmaceutical sciences, Chandigarh College of Pharmacy, Landran, Mohali, Punjab, 140307, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Modern technologies such as nanotechnology are being applied in almost every sector to deliver affordable, environmentally friendly products. The integration of nanotechnology in medicine has revolutionized drug delivery systems, with nanotechnology emerging as a promising frontier. This review explores the synthesis and characterization of nanotablet drug formulations designed to enhance their potential across various applications. By employing characterization techniques such as X-ray diffraction, electron microscopy, and physisorption analysis, researchers have developed innovative drug delivery systems like Sophora Alopecuroides nanotablets to treat deadly diseases such as cancer. Evaluation of pre- and post-compression results indicated that nanotablets exhibited good hardness and flow properties, making these formulations potential drug delivery systems for enhanced bioavailability and sustained release properties. Specifically, sublingual sufentanil nanotablets, such as Zalviso®, have demonstrated efficacy in managing moderate to severe pain in healthcare settings when used in conjunction with a PCA device. However, recent regulatory updates indicate changes in the marketing authorization status of Zalviso®. In conclusion, this novel approach for synthesizing nanotablets presents a promising avenue for diverse applications, and based on the results, it is worth considering for future work.

Indexed as

Drug Delivery SystemsNanoparticlesNanotechnologyAnimalsDelayed-Action PreparationsHumansDelayed-Action Preparationsand efficacy.applicationbioavailabilitydrug deliveryformulationsNanotabletsnanotechnologyPCA deviceregulatorysublingualZalviso

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.